Baker Bros. Advisors LP Genfit S.A. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.63 $55,936 - $68,153	-14,720 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.63 - $5.6 $49,643 - $76,585	-13,676 Reduced 48.16%	14,720 $71,000
Q2 2020 Aug 14, 2020	BUY	$5.2 - $22.0 $8,840 - $37,400	1,700 Added 6.37%	28,396 $156,000
Q1 2020 May 15, 2020	BUY	$10.95 - $20.76 $292,321 - $554,208	26,696 New	26,696 $395,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $180M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.